Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun Yu Liu

Showing results (81-90 of 296) with videos related to

Pageof 30
Sort By:
International Journal of Biological Macromolecules|October 23, 2020
Chemical structure and antioxidant activity of a polysaccharide from Siraitia grosvenoriiYong-Ming Zhu, Li-Chao Pan, Li-Juan Zhang, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 5, 2008
Pulmonary delivery of scutellarin solution and mucoadhesive particles in ratsXiao-Bin Liu, Jun-Xiao Ye, Li-Hui Quan, et al.
Asian Journal of Andrology|May 5, 2025
Novel biallelic HFM1 variants cause severe oligozoospermia with favorable intracytoplasmic sperm injection outcomeLiu Liu, Yi-Ling Zhou, Wei-Dong Tian, et al.
RSC Advances|May 6, 2022
Secondary metabolites from the endolichenic fungus <i>Ophiosphaerella korrae</i>Yue-Lan Li, Rong-Xiu Zhu, Gang Li, et al.
Angewandte Chemie (International Ed. in English)|January 11, 2022
Ligand Engineering toward the Trade-Off between Stability and Activity in Cluster CatalysisZong-Jie Guan, Rui-Lin He, Shang-Fu Yuan, et al.
Biochemical Pharmacology|January 11, 2012
Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3Kuen-Feng Chen, Hui-Ling Chen, Chun-Yu Liu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 2, 2022
CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancerChih-Yi Lin, Chung-Jen Yu, Chun-Yu Liu, et al.
Journal of the Chinese Medical Association : JCMA|May 12, 2010
Severe extensive bone marrow necrosis from miliary tuberculosis without granulomas and pulmonary presentationsYun-Hsuan Lee, Ying-Chung Hong, Ching-Fen Yang, et al.
Clinical and Experimental Medicine|October 31, 2025
Targeting SET to counteract Lyn activation demonstrates anti-cancer potential in diffuse large B-cell lymphomaJi-Lin Chen, Pei-Yi Chu, Chun-Teng Huang, et al.
Breast Cancer Research and Treatment|March 17, 2017
A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese womenLing-Ming Tseng, Jen-Hwey Chiu, Chun-Yu Liu, et al.
Pageof 30

Showing results (81-90 of 296) with videos related to

Sort By:
Pageof 30
International Journal of Biological Macromolecules|October 23, 2020
Chemical structure and antioxidant activity of a polysaccharide from Siraitia grosvenoriiYong-Ming Zhu, Li-Chao Pan, Li-Juan Zhang, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 5, 2008
Pulmonary delivery of scutellarin solution and mucoadhesive particles in ratsXiao-Bin Liu, Jun-Xiao Ye, Li-Hui Quan, et al.
Asian Journal of Andrology|May 5, 2025
Novel biallelic HFM1 variants cause severe oligozoospermia with favorable intracytoplasmic sperm injection outcomeLiu Liu, Yi-Ling Zhou, Wei-Dong Tian, et al.
RSC Advances|May 6, 2022
Secondary metabolites from the endolichenic fungus <i>Ophiosphaerella korrae</i>Yue-Lan Li, Rong-Xiu Zhu, Gang Li, et al.
Angewandte Chemie (International Ed. in English)|January 11, 2022
Ligand Engineering toward the Trade-Off between Stability and Activity in Cluster CatalysisZong-Jie Guan, Rui-Lin He, Shang-Fu Yuan, et al.
Biochemical Pharmacology|January 11, 2012
Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3Kuen-Feng Chen, Hui-Ling Chen, Chun-Yu Liu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 2, 2022
CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancerChih-Yi Lin, Chung-Jen Yu, Chun-Yu Liu, et al.
Journal of the Chinese Medical Association : JCMA|May 12, 2010
Severe extensive bone marrow necrosis from miliary tuberculosis without granulomas and pulmonary presentationsYun-Hsuan Lee, Ying-Chung Hong, Ching-Fen Yang, et al.
Clinical and Experimental Medicine|October 31, 2025
Targeting SET to counteract Lyn activation demonstrates anti-cancer potential in diffuse large B-cell lymphomaJi-Lin Chen, Pei-Yi Chu, Chun-Teng Huang, et al.
Breast Cancer Research and Treatment|March 17, 2017
A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese womenLing-Ming Tseng, Jen-Hwey Chiu, Chun-Yu Liu, et al.
Pageof 30